Ingevity Corporation (NGVT)
Ingevity Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Ingevity Corporation (NGVT) is a Chemicals - Specialty company based in US with a market capitalization of $2.4B. Revenue declined 17.0% year-over-year and the company generated $273.5M in free cash flow. This page tracks NGVT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 1.6K employees · IPO May 3, 2016
Valuation
Valuation & price
$67.58 · as of May 17, 2026 · -13.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
79.74
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$2.4B
Market cap
-17.0%
Revenue growth (YoY)
39.5%
Gross margin
$273.5M
Free cash flow (USD)
$1.2B
Net debt
-0.3%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Basic Materials
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 7, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventCFO AppointmentJun 24, 2026Filing
- Insider sellInsider Sell $34KDYER TERRANCE M · SVP, Chief HR Officer · $34KJun 1, 2026Filing
- Quarterly report10-Q FiledMay 7, 2026Filing
- 8-K eventEarnings ReleaseMay 6, 2026Filing
- 8-K eventAnnual Meeting ResultsMay 4, 2026Filing
- 8-K eventBusiness SaleApr 15, 2026Filing
Questions
Frequently asked questions
What is Ingevity Corporation's market cap?
Ingevity Corporation (NGVT) has a market capitalization of $2.4B.
What is NGVT's P/E ratio?
A meaningful P/E ratio is not available for NGVT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is NGVT's price-to-book (P/B) ratio?
NGVT trades at 79.74 times book value per share.
Are insiders buying NGVT stock?
SEC Form 4 filings show no open-market insider buys at Ingevity Corporation in the last 90 days (1 sell).
Same arena
Related companies in Chemicals - Specialty
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.